Literature DB >> 20150574

Mosaicism in osteopathia striata with cranial sclerosis.

Dennis J Joseph1, Shoji Ichikawa, Michael J Econs.   

Abstract

CONTEXT: Osteopathia striata with cranial sclerosis is an X-linked dominant condition caused by mutations in the WTX gene, resulting in linear striations in long bones in combination with cranial sclerosis. This condition is usually lethal in males. OBJECTIVE/PATIENT: Our aim was to determine the underlying genetic cause in a 37-yr-old male with this condition.
DESIGN: DNA sequencing of peripheral blood and hair was performed to identify mutations in WTX. Quantitative PCR was performed to determine gene copy number variation.
RESULTS: DNA sequenced from peripheral blood revealed the presence of two alleles at the 1108th position of the WTX gene. Subsequent DNA sequencing of hair follicles and quantitative PCR confirmed the presence of mosaicism.
CONCLUSION: A novel mutation (c.1108G>T) found in our patient results in a truncated protein (E370X). Our patient represents the first confirmed case of mosaicism in osteopathia striata with cranial sclerosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20150574      PMCID: PMC2853980          DOI: 10.1210/jc.2009-2343

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

1.  An X chromosome gene, WTX, is commonly inactivated in Wilms tumor.

Authors:  Miguel N Rivera; Woo Jae Kim; Julie Wells; David R Driscoll; Brian W Brannigan; Moonjoo Han; James C Kim; Andrew P Feinberg; William L Gerald; Sara O Vargas; Lynda Chin; A John Iafrate; Daphne W Bell; Daniel A Haber
Journal:  Science       Date:  2007-01-04       Impact factor: 47.728

2.  WTX is rarely mutated in acute myeloid leukemia.

Authors:  Carolyn Owen; Priya Virappane; Mary Alikian; Irina Stasevich; Karin Summers; Debbie Lillington; Dominique Bonnet; Alan Burnett; Ken Mills; T Andrew Lister; Jude Fitzgibbon
Journal:  Haematologica       Date:  2008-05-06       Impact factor: 9.941

3.  Clinical vignette: osteopathia striata with cranial sclerosis.

Authors:  C M Lazar; E M Braunstein; M J Econs
Journal:  J Bone Miner Res       Date:  1999-01       Impact factor: 6.741

4.  Osteopathia striata with cranial sclerosis owing to WTX gene defect.

Authors:  Bram Perdu; Fenna de Freitas; Suzanne G M Frints; Meyke Schouten; Connie Schrander-Stumpel; Mafalda Barbosa; Jorge Pinto-Basto; Margarida Reis-Lima; Marie-Christine de Vernejoul; Kristin Becker; Marie-Louise Freckmann; Kathlijn Keymolen; Eric Haan; Ravi Savarirayan; Rainer Koenig; Bernhard Zabel; Filip M Vanhoenacker; Wim Van Hul
Journal:  J Bone Miner Res       Date:  2010-01       Impact factor: 6.741

Review 5.  Osteopathia striata with cranial sclerosis: literature reappraisal argues for X-linked inheritance.

Authors:  C Behninger; H D Rott
Journal:  Genet Couns       Date:  2000

6.  Germline mutations in WTX cause a sclerosing skeletal dysplasia but do not predispose to tumorigenesis.

Authors:  Zandra A Jenkins; Margriet van Kogelenberg; Tim Morgan; Aaron Jeffs; Ryuji Fukuzawa; Esther Pearl; Christina Thaller; Anne V Hing; Mary E Porteous; Sixto Garcia-Miñaur; Axel Bohring; Didier Lacombe; Fiona Stewart; Torunn Fiskerstrand; Laurence Bindoff; Siren Berland; Lesley C Adès; Michel Tchan; Albert David; Louise C Wilson; Raoul C M Hennekam; Dian Donnai; Sahar Mansour; Valérie Cormier-Daire; Stephen P Robertson
Journal:  Nat Genet       Date:  2008-12-14       Impact factor: 38.330

7.  Wilms tumor genetics: mutations in WT1, WTX, and CTNNB1 account for only about one-third of tumors.

Authors:  E Cristy Ruteshouser; Stephen M Robinson; Vicki Huff
Journal:  Genes Chromosomes Cancer       Date:  2008-06       Impact factor: 5.006

8.  Mutational analysis of WTX gene in Wnt/ beta-catenin pathway in gastric, colorectal, and hepatocellular carcinomas.

Authors:  Nam J Yoo; S Kim; Sug H Lee
Journal:  Dig Dis Sci       Date:  2008-08-22       Impact factor: 3.199

  8 in total
  6 in total

Review 1.  Sclerosing bone disorders: a lot of knowns but still some unknowns.

Authors:  Wim Van Hul
Journal:  Bonekey Rep       Date:  2012-06-06

Review 2.  WTX R353X mutation in a family with osteopathia striata and cranial sclerosis (OS-CS): case report and literature review of the disease clinical, genetic and radiological features.

Authors:  Anna Maria Zicari; Luigi Tarani; Daniela Perotti; Laura Papetti; Francesco Nicita; Natascia Liberati; Alberto Spalice; Guglielmo Salvatori; Federica Guaraldi; Marzia Duse
Journal:  Ital J Pediatr       Date:  2012-06-20       Impact factor: 2.638

3.  Whole Exome Sequencing Provides the Correct Diagnosis in a Case of Osteopathia Striata with Cranial Sclerosis: Case Report of a Novel Frameshift Mutation in AMER1.

Authors:  José María García-Aznar; Noelia Ramírez; David De Uña; Elisa Santiago; Lorenzo Monserrat
Journal:  J Pediatr Genet       Date:  2020-04-21

4.  Mosaic Deletions of Known Genes Explain Skeletal Dysplasias With High and Low Bone Mass.

Authors:  Mari Muurinen; Fulya Taylan; Symeon Tournis; Jesper Eisfeldt; Alexia Balanika; Heleni Vastardis; Sirpa Ala-Mello; Outi Mäkitie; Alice Costantini
Journal:  JBMR Plus       Date:  2022-07-05

Review 5.  High Fidelity of Mouse Models Mimicking Human Genetic Skeletal Disorders.

Authors:  Robert Brommage; Claes Ohlsson
Journal:  Front Endocrinol (Lausanne)       Date:  2020-02-04       Impact factor: 5.555

6.  The PPAR-γ antagonist T007 inhibits RANKL-induced osteoclastogenesis and counteracts OVX-induced bone loss in mice.

Authors:  Xiang Li; Lei Ning; Jianjun Ma; Ziang Xie; Xiangde Zhao; Gangliang Wang; Xinyu Wan; Pengcheng Qiu; Teng Yao; Haoming Wang; Shunwu Fan; Shuanglin Wan
Journal:  Cell Commun Signal       Date:  2019-10-26       Impact factor: 5.712

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.